Ashford Capital Management’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-8,180
| Closed | -$653K | – | 115 |
|
|
2021
Q1 | $653K | Hold |
8,180
| – | – | 0.06% | 83 |
|
|
2020
Q4 | $645K | Buy |
+8,180
| New | +$480K | 0.06% | 85 |
|
|
2019
Q4 | – | Sell |
-2,820
| Closed | -$211K | – | 95 |
|
|
2019
Q3 | $211K | Hold |
2,820
| – | – | 0.03% | 93 |
|
|
2019
Q2 | $227K | Buy |
+2,820
| New | +$198K | 0.03% | 95 |
|
|
2019
Q1 | – | Sell |
-3,450
| Closed | -$257K | – | 114 |
|
|
2018
Q4 | $257K | Hold |
3,450
| – | – | 0.04% | 108 |
|
|
2018
Q3 | $318K | Sell |
3,450
-600
| -15% | -$57.1K | 0.04% | 106 |
|
|
2018
Q2 | $398K | Hold |
4,050
| – | – | 0.05% | 91 |
|
|
2018
Q1 | $451K | Sell |
4,050
-400
| -9% | -$44.8K | 0.07% | 78 |
|
|
2017
Q4 | $458K | Hold |
4,450
| – | – | 0.07% | 80 |
|
|
2017
Q3 | $419K | Hold |
4,450
| – | – | 0.07% | 88 |
|
|
2017
Q2 | $347K | Hold |
4,450
| – | – | 0.06% | 88 |
|
|
2017
Q1 | $356K | Hold |
4,450
| – | – | 0.07% | 92 |
|
|
2016
Q4 | $350K | Hold |
4,450
| – | – | 0.07% | 92 |
|
|
2016
Q3 | $347K | Sell |
4,450
-210
| -5% | -$15.2K | 0.07% | 94 |
|
|
2016
Q2 | $320K | Sell |
4,660
-1,599
| -26% | -$110K | 0.07% | 95 |
|
|
2016
Q1 | $447K | Sell |
6,259
-3,310
| -35% | -$208K | 0.11% | 87 |
|
|
2015
Q4 | $595K | Hold |
9,569
| – | – | 0.14% | 79 |
|
|
2015
Q3 | $543K | Sell |
9,569
-181
| -2% | -$9.58K | 0.13% | 85 |
|
|
2015
Q2 | $523K | Hold |
9,750
| – | – | 0.12% | 93 |
|
|
2015
Q1 | $463K | Hold |
9,750
| – | – | 0.09% | 101 |
|
|
2014
Q4 | $422K | Hold |
9,750
| – | – | 0.08% | 110 |
|
|
2014
Q3 | $335K | Buy |
9,750
+1,100
| +13% | +$38.8K | 0.07% | 114 |
|
|
2014
Q2 | $317K | Hold |
8,650
| – | – | 0.06% | 118 |
|
|
2014
Q1 | $292K | Hold |
8,650
| – | – | 0.06% | 122 |
|
|
2013
Q4 | $293K | Hold |
8,650
| – | – | 0.06% | 119 |
|
|
2013
Q3 | $276K | Sell |
8,650
-1,850
| -18% | -$49.2K | 0.05% | 120 |
|
|
2013
Q2 | $237K | Buy |
+10,500
| New | +$227K | 0.05% | 127 |
|
Ashford Capital Management's CMD Position: Q2 2021 in Review
Ashford Capital Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 8,180 shares — an estimated $653K sold.
Ashford Capital Management first reported a position in CMD in Q2 2013 and held it in 27 quarters. The position peaked at $653K in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Ashford Capital Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Ashford Capital Management sold 8,180 Cantel Medical Corporation shares in Q2 2021, an estimated $653K.
- Ashford Capital Management first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 27 quarters.
- Ashford Capital Management's Cantel Medical Corporation position peaked at $653K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Ashford Capital Management's 13F filing for Q2 2021, filed 26 Aug 2021.